Godflesh Co-Founder Justin Broadrick Says Band Will End After Health Diagnosis

Justin Broadrick, singer and guitarist of the pioneering industrial metal duo Godflesh, has announced that the band's nearly four-decade career will soon come to an end, according to an interview published by The Guardian.

Broadrick, who turned 57 this year, told the publication that he had experienced groin pain for several years before a hernia became apparent following a 2024 performance in Sofia, Bulgaria. He said he continued performing live for another year, at times wearing up to two hernia belts simultaneously, before undergoing surgery in February this year. By that point, according to Broadrick, the hernia measured 13 centimeters.

In March, Broadrick shared a hospital photo and revealed that his condition had resulted from the physical strain of shouting over the band's music since he was 18 years old. He said doctors warned that continuing to perform in the same way could risk further damage to his abdominal wall.

Godflesh will release one more studio album this autumn, titled Decay, which was recorded prior to Broadrick's surgery. According to the report, the band may also release a second studio album along with archival material and remixes, but no further new music is planned beyond that.

Broadrick, who was also an early member of the grindcore band Napalm Death, is described in the report as having had a significant influence on the development of industrial and extreme metal genres. The article notes that his work has had an impact in unexpected musical circles, and mentions a connection to musician Phoebe Bridgers, though specific details of that collaboration were not fully outlined in the available material.

Despite the end of Godflesh, Broadrick indicated he intends to continue making music, including new projects described as "heavy, ugly" experiments, and said his interest in what he calls "outsider music" remains strong.